XtalPi Holdings (FRA:V0I) Revenue: €97.06 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:V0I XtalPi Holdings Ltd FRA:V0I
20 GF Score
Price €0.78
! 7 Warning Signs
View Full Analysis

What is XtalPi Holdings Revenue?

XtalPi Holdings FRA:V0I +0.65% 20 Revenue is €97.06 Mil as of Dec. 2025. GuruFocus rates FRA:V0I with a GF Score™ of 20/100. The stock has 7 warning signs investors should review.

XtalPi Holdings's revenue for the six months ended in Dec. 2025 was €34.62 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €97.06 Mil. XtalPi Holdings's Revenue per Share for the six months ended in Dec. 2025 was €0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03.

During the past 12 months, the average Revenue per Share Growth Rate of XtalPi Holdings was 59.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 74.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 5 years, XtalPi Holdings's highest 3-Year average Revenue per Share Growth Rate was 85.60% per year. The lowest was 74.60% per year. And the median was 80.10% per year.


XtalPi Holdings  (FRA:V0I) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


XtalPi Holdings Revenue Related Terms


XtalPi Holdings Revenue Historical Data

* Premium members only.

The historical data trend for XtalPi Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XtalPi Holdings Revenue Chart

XtalPi Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
8.73 18.06 22.40 34.95 97.32

XtalPi Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Revenue Get a 7-Day Free Trial 12.13 13.14 21.49 62.44 34.62

FRA:V0I vs VEEV, BTSG, HQY: Revenue Comparison

For the Health Information Services subindustry, XtalPi Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XtalPi Holdings Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, XtalPi Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where XtalPi Holdings's Revenue falls into.


FRA:V0I
20GF Score
XtalPi Holdings Ltd FRA:V0I
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XtalPi Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €97.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of €97.06 Mil mean?
XtalPi Holdings (FRA:V0I) has a Revenue of €97.06 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on XtalPi Holdings and its competitors.
Is XtalPi Holdings' Revenue too high?
XtalPi Holdings' current Revenue is €97.06 Mil. Overall, XtalPi Holdings has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does XtalPi Holdings' Revenue compare to VEEV and BTSG?
XtalPi Holdings' Revenue of €97.06 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on XtalPi Holdings and its competitors. XtalPi Holdings's current Revenue is €97.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XtalPi Holdings stock overvalued right now?
XtalPi Holdings (FRA:V0I) has a current Revenue of €97.06 Mil. The current Revenue is €97.06 Mil. XtalPi Holdings' overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For XtalPi Holdings (FRA:V0I), the current Revenue is €97.06 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

XtalPi Holdings Business Description

Other Exchanges 02228:Hong Kong
Address No. 2 Hongliu Road, 3rd floor, Second Phase of the International, Biomedical Industrial Park, Futian District, Shenzhen, CHN
XtalPi Holdings Ltd is a research platform company powered by artificial intelligence (AI) and robotics. It is dedicated to driving intelligent and digital transformation in the life sciences and materials sciences sectors. The company combines quantum physics, AI, cloud computing, and large-scale robotics to provide research & development solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and materials industries globally. The company has a single segment that is intelligent robotics solutions and drug discovery solutions (including one-stop drug discovery solutions). The firm generates the majority of its revenue from Drug discovery solutions, and a smaller portion of revenue is derived from AI for Science intelligent solutions.
20GF Score

Get the complete analysis for FRA:V0I

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.78
Price